Related references
Note: Only part of the references are listed.Side effects of drugs for osteoporosis and metastatic bone disease
Michael Kriegbaum Skjodt et al.
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY (2019)
Biomarkers of Osteoporosis: An Update
Bushra Parveen et al.
ENDOCRINE METABOLIC & IMMUNE DISORDERS-DRUG TARGETS (2019)
Therapeutic Anabolic and Anticatabolic Benefits of Natural Chinese Medicines for the Treatment of Osteoporosis
Jianbo He et al.
FRONTIERS IN PHARMACOLOGY (2019)
The effect of raloxifene on bone marrow adipose tissue and bone turnover in postmenopausal women with osteoporosis
Kerensa M. Beekman et al.
BONE (2019)
Inhibition of RANKL-stimulated osteoclast differentiation by Schisandra chinensis through down-regulation of NFATc1 and c-fos expression
Eun-Jung Kim et al.
BMC COMPLEMENTARY AND ALTERNATIVE MEDICINE (2018)
Bmp Induces Osteoblast Differentiation through both Smad4 and mTORC1 Signaling
Courtney M. Karner et al.
MOLECULAR AND CELLULAR BIOLOGY (2017)
Current knowledge of Schisandra chinensis (Turcz.) Baill. (Chinese magnolia vine) as a medicinal plant species: a review on the bioactive components, pharmacological properties, analytical and biotechnological studies
Agnieszka Szopa et al.
PHYTOCHEMISTRY REVIEWS (2017)
Improvement of osteoporosis by Lycium chinense administration in ovariectomized mice
Mi Hye Kim et al.
JOURNAL OF THE CHINESE MEDICAL ASSOCIATION (2017)
Effects of Osteo-F, a new herbal formula, on osteoporosis via up-regulation of Runx2 and Osterix
Ji Eun Lee et al.
RSC ADVANCES (2017)
Lycium Barbarum: A Traditional Chinese Herb and A Promising Anti-Aging Agent
Yanjie Gao et al.
AGING AND DISEASE (2017)
Osteoporosis treatment: recent developments and ongoing challenges
Sundeep Khosla et al.
LANCET DIABETES & ENDOCRINOLOGY (2017)
Use of bone turnover markers in postmenopausal osteoporosis
Richard Eastell et al.
LANCET DIABETES & ENDOCRINOLOGY (2017)
Bone biomarker for the clinical assessment of osteoporosis: recent developments and future perspectives
Tsung-Rong Kuo et al.
BIOMARKER RESEARCH (2017)
Serum osteopontin levels in relation to bone mineral density and bone turnover markers in postmenopausal women
Qiu-Shi Wei et al.
SCANDINAVIAN JOURNAL OF CLINICAL & LABORATORY INVESTIGATION (2016)
Epigenetic Regulation of Bone Remodeling and Its Impacts in Osteoporosis
Chafik Ghayor et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2016)
Postmenopausal Osteoporosis
Dennis M. Black et al.
NEW ENGLAND JOURNAL OF MEDICINE (2016)
Osteoblast Differentiation at a Glance
Arkady Rutkovskiy et al.
MEDICAL SCIENCE MONITOR BASIC RESEARCH (2016)
Regulation of osteoclastic and osteoblastic differentiation marker expressions in osteoblast-like saos-2 cells by Eucommia ulmoides
Ji Eun Lee et al.
ORIENTAL PHARMACY AND EXPERIMENTAL MEDICINE (2016)
Structure and molecular regulation of bone matrix proteins
Pamela Gehron Robey et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2010)
Epidemiology of osteoporosis
Christopher Holroyd et al.
BEST PRACTICE & RESEARCH CLINICAL ENDOCRINOLOGY & METABOLISM (2008)
Incidence and economic burden of osteoporosis-related fractures in the United States, 2005-2025
Russel Burge et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2007)
Effect of parathyroid hormone (1-34) on fractures and bone mineral density in postmenopausal women with osteoporosis.
RM Neer et al.
NEW ENGLAND JOURNAL OF MEDICINE (2001)
Share Paper
